ERF3b, a biomarker for hepatocellular carcinoma, influences cell cycle and phosphoralation status of 4E-BP1

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Li, Man ^a   Wang, Jian ^a,b   Yang, Lei ^a   Gao, Ping ^a   Tian, Qing Bao ^a   Liu, Dian Wu ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI NORTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR GTP BINDING SUBUNIT 3B; INITIATION FACTOR 4E BINDING PROTEIN 1; MESSENGER RNA; RNA 18S; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CHILD; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS B; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WEAK CATION EXCHANGE MAGNETIC BEAD PURIFICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CHILD; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE TERMINATION FACTORS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; ROC CURVE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84899862707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086371     Document Type: Article

References (26)

1. Ganem D, Prince AM (2004) Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 350: 1118-1129. (Pubitemid 38298992)
2. Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15: 225-236.
3. Petricoin EF, 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, et al. (2002) Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94: 1576-1578. (Pubitemid 35277282)
4. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, et al. (2006) Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368: 1012-1021. (Pubitemid 44353670)
5. Liu C, Pan C, Liang Y (2012) Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma. Exp Ther Med 3: 1005-1009.
6. Leal MF, Chung J, Calcagno DQ, Assumpcao PP, Demachki S, et al. (2012) Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One 7: e42255.
7. Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JT, et al. (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51: 2236-2244. (Pubitemid 41692565)
8. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945. (Pubitemid 39071573)
9. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12: 9-22. (Pubitemid 47001784)
10. Srinivas PR, Verma M, Zhao Y, Srivastava S (2002) Proteomics for cancer biomarker discovery. Clin Chem 48: 1160-1169. (Pubitemid 34809820)
11. Wagner PD, Verma M, Srivastava S (2004) Challenges for biomarkers in cancer detection. Ann N Y Acad Sci 1022: 9-16. (Pubitemid 38951575)
12. Li M, Wang J, Dai E, Liu D (2011) [Identification and investigation of disease-related peptides in sera from patients with chronic hepatitis B]. Wei Sheng Yan Jiu 40: 315-319.
13. Chauvin C, Salhi S, Le Goff C, Viranaicken W, Diop D, et al. (2005) Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation. Mol Cell Biol 25: 5801-5811. (Pubitemid 40946538)
14. Hoshino S, Imai M, Mizutani M, Kikuchi Y, Hanaoka F, et al. (1998) Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1. J Biol Chem 273: 22254-22259. (Pubitemid 28399781)
15. Hoshino S, Miyazawa H, Enomoto T, Hanaoka F, Kikuchi Y, et al. (1989) A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells. EMBO J 8: 3807-3814. (Pubitemid 20016062)
16. Jakobsen CG, Segaard TM, Jean-Jean O, Frolova L, Justesen J (2001) [Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo]. Mol Biol (Mosk) 35: 672-681.
17. Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, et al. (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14: 4365-4373.
18. Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov S, et al. (1995) Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 14: 4065-4072.
19. Valouev IA, Kushnirov VV, Ter-Avanesyan MD (2002) Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation. Cell Motil Cytoskeleton 52: 161-173. (Pubitemid 34701105)
20. Basu J, Williams BC, Li Z, Williams EV, Goldberg ML (1998) Depletion of a Drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis. Cell Motil Cytoskeleton 39: 286-302. (Pubitemid 28153232)
21. Malta-Vacas J, Aires C, Costa P, Conde AR, Ramos S, et al. (2005) Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types. J Clin Pathol 58: 621-625. (Pubitemid 40814023)
22. Chauvin C, Salhi S, Jean-Jean O (2007) Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway. Mol Cell Biol 27: 5619-5629. (Pubitemid 47257820)
23. Corradetti MN, Guan KL (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25: 6347-6360. (Pubitemid 44582281)
24. Pons B, Armengol G, Livingstone M, Lopez L, Coch L, et al. (2012) Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells. Oncol Rep 27: 225-231.
25. Chang JT, Chen LC, Wei SY, Chen YJ, Wang HM, et al. (2006) Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry - plasma peptidomes from nasopharyngeal cancer patients for example. Clin Biochem 39: 1144-1151. (Pubitemid 44838573)
26. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)